Previous Close | 0.8500 |
Open | 0.8500 |
Bid | 0.8500 x N/A |
Ask | 1.1500 x N/A |
Day's Range | 0.8500 - 0.8500 |
52 Week Range | 0.6000 - 1.5000 |
Volume | |
Avg. Volume | 0 |
Market Cap | 4.517M |
Beta (5Y Monthly) | -0.58 |
PE Ratio (TTM) | 21.25 |
EPS (TTM) | 0.0400 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Phoenix Canada Oil Company Limited (TSXV:PCO) ("Phoenix") and ZYUS Life Sciences Inc. ("ZYUS" or the "Company"), a private Canadian life sciences company, together announce that they have entered into a Definitive Agreement dated November 15, 2022 (the "Agreement"). The Agreement is the Definitive Agreement contemplated by the non-binding letter of intent Phoenix and ZYUS entered into on May 27, 2022 and announced by press release dated May 30, 2022.
Phoenix Canada Oil Company Limited (TSXV:PCO) ("Phoenix" or the "Company") is pleased to provide an update to the Company's previously announced non-binding letter of intent (the "LOI") dated May 27, 2022 with ZYUS Life Sciences Inc. ("ZYUS"), a private Canadian life sciences company.